03672nam 2200889z- 450 991058021310332120220706(CKB)5690000000011957(oapen)https://directory.doabooks.org/handle/20.500.12854/87541(oapen)doab87541(EXLCZ)99569000000001195720202207d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierThe Role of Fibrinolytic System in Health and DiseaseBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (170 p.)3-0365-4619-7 3-0365-4620-0 This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O'Connell; receptor of urokinase type plasminogen activator, by Dr. M. Ploug et al.; tissue plasminogen activator induction in purjinjen neuron, by Dr. Seeds; fibrinolysis from the blood to the brain, by Dr. Robert Metcalf; tissue plasminogen activator induces the opening of the blood-brain barrier, by Dr. M. Yepes; fibrinolysis shutdown in trauma: a historical review and clinical application, by Drs. Hunter Moore and Ernest Moore; fibrinolysis in immunity, by Drs. K. Kolev and Robert Medcalf; the role of plasminogen activator inhibitor 1, by Drs. M. Erin, A.E. Boe, and E.A. Klyachko; and finally, persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients, by J.P. Meizoso.Biology, life sciencesbicsscResearch & information: generalbicsscacute lung injury and repair and pleural injury and pleural organizationagingantiplasminbrown adipose tissuecancercarboxypeptidasecardiovascular diseaseclot retractionclot stabilitycoagulationCOVID-19Factor XIIIfibrinolysisfibrosisimmune responseinflammationNETsneurodegenerationobesityobstructive sleep apnoeaOSAPA systemPAI-1PAI-2plasminplasminogen activationplasminogen activatorplasminogen activator inhibitor 1 (PAI-1)plasminogen activator inhibitor-1plateletsproCPBproCPRproCPUrenin-aldosterone-angiotensin-system (RAAS)shearTAFIthrombinthrombin activatable fibrinolysis inhibitortissue-type plasminogen activator (tPA)uPAuPARurokinase plasminogen activatorurokinase plasminogen activator receptorurokinase-type plasminogen activator (uPA)Biology, life sciencesResearch & information: generalKwaan Hau Cedt1313401Kwaan Hau CothBOOK9910580213103321The Role of Fibrinolytic System in Health and Disease3031385UNINA01623nam0 22003613i 450 CFI000276120251003044106.020160609d1983 ||||0itac50 baitaitz01i xxxe z01nz01ncRDAcarrierˆLa ‰previdenza dei dirigenti di azienda nel sistema pensionistico italianocontributi di Natale Graziani ... [et al.]Rist. con gli atti della tavola rotonda sul tema presieduta da Lionello Levi SandriMilanoA. Giuffrè1983VII, 288 p.25 cmIn testa al front.: Istituto nazionale di previdenza per i dirigenti di aziende industriali.Previdenza socialeItaliaFIRCFIC069595E368.412368.4PREVIDENZA SOCIALE21Graziani, NataleCFIV002161Istituto nazionale di previdenza per i dirigenti di aziende industrialiRAVV068698070251182INPDAIRAVV068699Istituto nazionale di previdenza per i dirigenti di aziende industrialiITIT-00000020160609IT-BN0095 IT-NA0457 NAP 01D $NAP BISALA 1 Libri da 1 a 960CFI0002761Biblioteca Centralizzata di Ateneo1 v. 01D (AR) 8 813 01AR 0070088135 VMA 1 v.Y 2015120120151201 01 BIPrevidenza dei dirigenti di azienda nel sistema pensionistico italiano61590UNISANNIO